To access this element change to forms mode OFF
Grant Award View - GA279506
Improving estimates of antimalarial drug resistance
GA ID:
GA279506
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
23-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$880,838.12
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Improving estimates of antimalarial drug resistance
Purpose:
Antimalarial drugs are essential for the elimination of malaria. Resistance to all currently available antimalarials, including the pivotal artemisinin derivatives, has emerged and is spreading. This project aims to generate the first data-driven, predictive maps of the changing landscape of artemisinin resistance in Asia. These maps fill in the gaps where no information is available and can be used by health agencies to guide new polices about where and when the drug is appropriate to use.
GO ID:
GO Title:
Ideas Grants 2022
InternalReferenceId:
2022/GNT2019093
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA